A comparable study in Ewing's sarcoma tumors and cell lines found that CD133+ cells were low or absent in most tumors, and the CD133+ fraction was more resistant to chemotherapy in only some of the tumors [101]. This evidence concerns the gene PROM1 and Ewing sarcoma.